- Home
- VACH vs VNDA Comparison
VACH vs VNDA Comparison
Compare VACH & VNDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VACH
- VNDA
- Stock Information
- Founded
- VACH 2023
- VNDA 2002
- Country
- VACH United States
- VNDA United States
- Employees
- VACH N/A
- VNDA N/A
- Industry
- VACH
- VNDA Biotechnology: Pharmaceutical Preparations
- Sector
- VACH
- VNDA Health Care
- Exchange
- VACH NYSE
- VNDA Nasdaq
- Market Cap
- VACH 274.7M
- VNDA 270.2M
- IPO Year
- VACH 2024
- VNDA 2006
- Fundamental
- Price
- VACH $10.03
- VNDA $5.00
- Analyst Decision
- VACH
- VNDA Strong Buy
- Analyst Count
- VACH 0
- VNDA 2
- Target Price
- VACH N/A
- VNDA $15.50
- AVG Volume (30 Days)
- VACH 7.9K
- VNDA 623.2K
- Earning Date
- VACH 01-01-0001
- VNDA 11-06-2024
- Dividend Yield
- VACH N/A
- VNDA N/A
- EPS Growth
- VACH N/A
- VNDA N/A
- EPS
- VACH N/A
- VNDA N/A
- Revenue
- VACH N/A
- VNDA $190,858,000.00
- Revenue This Year
- VACH N/A
- VNDA $5.13
- Revenue Next Year
- VACH N/A
- VNDA $42.65
- P/E Ratio
- VACH N/A
- VNDA N/A
- Revenue Growth
- VACH N/A
- VNDA N/A
- 52 Week Low
- VACH $9.97
- VNDA $3.39
- 52 Week High
- VACH $10.10
- VNDA $6.75
- Technical
- Relative Strength Index (RSI)
- VACH N/A
- VNDA 52.22
- Support Level
- VACH N/A
- VNDA $4.56
- Resistance Level
- VACH N/A
- VNDA $5.55
- Average True Range (ATR)
- VACH 0.00
- VNDA 0.22
- MACD
- VACH 0.00
- VNDA 0.04
- Stochastic Oscillator
- VACH 0.00
- VNDA 44.44
About VACH VOYAGER ACQUISITION CORP.
Voyager Acquisition Corp is a blank check company.
About VNDA Vanda Pharmaceuticals Inc.
Vanda Pharmaceuticals Inc is a biopharmaceutical company engaged in the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. Its commercial portfolio comprises three products, HETLIOZ for the treatment of Non-24-Hour Sleep-Wake Disorder (Non-24) & nighttime sleep disturbances in Smith-Magenis Syndrome (SMS), Fanapt for the treatment of schizophrenia and PONVORY. Its other products include VHX-896, ASO Molecules, VQW-765, Tradipitant, VTR-297 and VHX-896. The majority of revenue is derived from HETLIOZ product sales.